{
   "usage" : "diabetes2",
   "reference" : "Each of the 699 patients in the experiment were randomized to one of the\nfollowing treatments: (1) continued treatment with metformin\n(coded as met), (2) formin combined with rosiglitazone (coded as\nrosi), or or (3) a lifestyle-intervention program (coded as\nlifestyle).",
   "title" : "Type 2 Diabetes Clinical Trial for Patients 10-17 Years Old",
   "description" : "Description\nThree treatments were compared to test their relative efficacy\n(effectiveness) in treating Type 2 Diabetes in patients aged 10-17 who were\nbeing treated with metformin. The primary outcome was lack of glycemic\ncontrol (or not); lacking glycemic control means the patient still needed\ninsulin, which is not the preferred outcome for a patient.",
   "parameters" : {
      "treatment" : "The treatment the patient received.",
      "outcome" : "Whether there patient still needs insulin (failure)\nor met a basic positive outcome bar (success)."
   },
   "format" : "A data frame with 699 observations on the following 2 variables."
}
